Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Assets (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Return on Assets for 13 consecutive years, with 0.23% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 5.0% year-over-year to 0.23%, compared with a TTM value of 0.23% through Dec 2025, up 5.0%, and an annual FY2025 reading of 0.25%, up 3.0% over the prior year.
  • Return on Assets was 0.23% for Q4 2025 at Enanta Pharmaceuticals, up from 0.28% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.15% in Q1 2021 and bottomed at 0.45% in Q2 2022.
  • Average Return on Assets over 5 years is 0.3%, with a median of 0.3% recorded in 2024.
  • The sharpest move saw Return on Assets dropped -27bps in 2022, then rose 13bps in 2023.
  • Year by year, Return on Assets stood at 0.36% in 2021, then increased by 7bps to 0.33% in 2022, then increased by 9bps to 0.3% in 2023, then grew by 5bps to 0.29% in 2024, then increased by 19bps to 0.23% in 2025.
  • Business Quant data shows Return on Assets for ENTA at 0.23% in Q4 2025, 0.28% in Q3 2025, and 0.29% in Q2 2025.